Acurx Pharmaceuticals, Inc.
ACXP
$1.42
-$0.01-0.77%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)
8/19/2026
-
TipRanks
8/17/2026
-
PR Newswire
8/15/2026
-
TipRanks
8/14/2026
-
Seeking Alpha: Transcripts
8/14/2026
-
SeekingAlpha
8/14/2026
-
TipRanks
8/14/2026
-
GuruFocus
8/14/2026
-
PR Newswire
8/13/2026
-
The Cerbat Gem
8/12/2026
-
TipRanks
8/12/2026
-
PR Newswire
8/10/2026
-
PR Newswire
8/3/2026
-
TipRanks
7/14/2026
-
PR Newswire
7/8/2026
-
PR Newswire
6/8/2026
-
Zacks Investment Research
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
SeekingAlpha
5/12/2026
-
Seeking Alpha: Transcripts
5/12/2026
-
The Cerbat Gem
5/12/2026
-
Seeking Alpha - Healthcare
5/12/2026
-
PR Newswire
5/5/2026
-
The Cerbat Gem
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
917 533 1469
Address
259 Liberty Avenue
Staten Island, NY 10305
Staten Island, NY 10305
Country
Year Founded
Business Description
Sector
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company’s lead antibiotic candidate is...
more